[Paranasal sinus reconstruction with bioactive bone cement--a 5-year animal experiment study]

Area of Science:

• Biomaterials Science
• Orthopedic Surgery
• Craniofacial Reconstruction

Background:

• Polymethylmethacrylate (PMMA) bone cements are widely used in orthopedic and craniofacial surgery.
• Limitations of traditional PMMA cements include lack of biological integration and potential for inflammatory reactions.
• Bioactive materials offer the potential for enhanced osseointegration and reduced adverse effects.

Purpose of the Study:

• To evaluate the efficacy and biocompatibility of a newly developed bioactivated bone cement, Palavital, for craniofacial reconstruction.
• To assess the potential for true bonding between Palavital and the bony implantation bed.
• To investigate the long-term stability and inflammatory response to Palavital implants.

Main Methods:

• Palavital, a novel bone cement composed of PMMA, glass fibers, and bioactive glass ceramic, was used for frontal sinus and skull reconstruction in 9 dogs.
• Implants were assessed over follow-up periods ranging from 14 days to 5 years.
• Evaluation methods included computed tomography (CT) and histological analysis.

Main Results:

• All Palavital implants were well-tolerated, with no observed inflammatory reactions.
• Histological and tomographic assessments confirmed a demonstrable bond between the bone and the implant.
• The bioactive glass ceramic particles on the surface facilitated osseointegration.

Conclusions:

• Palavital represents a significant advancement in bone cement technology.
• The bioactivated nature of Palavital promotes true bonding with bone tissue.
• This novel cement shows potential as an improved alternative to conventional PMMA-based bone cements for craniofacial and orthopedic applications.